Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IPSEY
Recent news which mentions IPSEY
FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
June 11, 2024
Tickers
GNFT
IPSEF
IPSEY
NEWS
Tags
Media
General
IPSEF
From
Benzinga
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
Tickers
ABOS
BMRN
EXEL
HALO
Tags
IPSEY
EXEL
BMRN
From
InvestorPlace
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
August 21, 2023
Tickers
EXEL
IPSEF
IPSEY
RHHBF
Tags
Market News
IPSEY
RHHBY
From
Benzinga
Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class
June 30, 2023
Tickers
CBAY
GNFT
IPSEY
Tags
Market News
Analyst Color
Analyst Ratings
From
Benzinga
Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
June 30, 2023
Tickers
GNFT
IPSEY
Tags
Health Care
Penny Stocks
News
From
Benzinga
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
May 22, 2023
Tickers
CBAY
DRRX
GNFT
ICPT
Tags
GNFT
Expert Ideas
ICPT
From
Benzinga
Why These Two Biotech Stocks Blasted Higher This Week
January 13, 2023
Tickers
ALBO
AZN
CINC
IPSEY
Tags
IPSEY
AZN
CINC
From
Motley Fool
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday
January 09, 2023
Tickers
ALBO
DCT
IPSEY
Tags
ALBO
Recent Press Releases
IPSEY
From
Motley Fool
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
January 09, 2023
Tickers
ALBO
IPSEF
IPSEY
Tags
Benzinga
Biotech
Movers
From
Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
Tickers
EXEL
IPSEY
RHHBY
TAK
Tags
Biotech
TAK
Health Care
From
Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
November 09, 2022
Tickers
IPSEF
IPSEY
MACK
Tags
Trading Ideas
Penny Stocks
Health Care
From
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
Tickers
APLS
ARDX
AZN
FOLD
Tags
IPSEY
IMGN
Market News
From
Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Tickers
ALNY
AMLX
AZN
BLUE
Tags
FDA
IBB
GSK
From
Benzinga
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
September 19, 2022
Tickers
GNFT
IPSEY
Tags
Market News
M&A
IPSEY
From
Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
August 03, 2022
Tickers
IPSEF
IPSEY
MACK
Tags
Market News
IPSEY
why it's moving
From
Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Tickers
AFIB
AGRX
AGTC
AMST
Tags
AXSM
EAR
PSNY
From
Benzinga
Why Adaptimmune Therapeutics Stock Is Popping Today
June 27, 2022
Tickers
ADAP
EPZM
IPSEY
Tags
IPSEY
EPZM
ADAP
From
Motley Fool
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
June 27, 2022
Tickers
AFIB
AGRX
AGTC
ARMP
Tags
News
Mid/Day Movers
AVTX
From
Benzinga
Why Epizyme Stock Is Soaring Today
June 27, 2022
Tickers
EPZM
IPSEY
Tags
Market News
Recent Press Releases
EPZM
From
Motley Fool
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
AZNCF
DSNKY
Small Cap
From
Benzinga
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
June 27, 2022
Tickers
EPZM
IPSEF
IPSEY
Tags
IPSEY
why it's moving
M&A
From
Benzinga
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
May 17, 2022
Tickers
BMY
ETSY
EXEL
IPSEY
Tags
Recent Press Releases
EXEL
TKPHF
From
Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Tickers
ACAD
AQST
BIIB
BLTE
Tags
Small Cap
Financing
RYTM
From
Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
May 03, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
IPSEF
General
IPSEY
From
Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
March 25, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
IPSEY
IPSEF
General
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
General
RHHVF
Liver Cancer
From
Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
January 24, 2022
Tickers
ABBV
GILD
HAL
IBM
Tags
A Peek Into The Markets
HAL
Benzinga
From
Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
January 24, 2022
Tickers
IPSEF
IPSEY
Tags
Market News
IPSEY
IPSEF
From
Benzinga
GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters
December 17, 2021
Tickers
BABA
FUTU
GNFT
IPSEY
Tags
BABA
IPSEY
NVAX
From
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 17, 2021
Tickers
ABEO
ADGI
BLIN
CERN
Tags
ABEO
EJH
KPRX
From
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.